These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28045974)

  • 41. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
    Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN
    Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody reactions of horses against various domains of the EHV-1 receptor-binding protein gD1.
    Schramm A; Ackermann M; Eichwald C; Aguilar C; Fraefel C; Lechmann J
    PLoS One; 2024; 19(7):e0301987. PubMed ID: 38995916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR; Bateman H; Williams J; Didlick S
    Vet Microbiol; 2003 Jan; 91(1):23-39. PubMed ID: 12441229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful control of winter pyrexias caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage.
    Bannai H; Mae N; Ode H; Nemoto M; Tsujimura K; Yamanaka T; Kondo T; Matsumura T
    Clin Vaccine Immunol; 2014 Aug; 21(8):1070-6. PubMed ID: 24872513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential of DNA-mediated vaccination for equine herpesvirus 1.
    Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroprevalence of equine herpesvirus 1 in thoroughbred foals before and after weaning.
    Gilkerson JR; Love DN; Drummer HE; Studdert MJ; Whalley JM
    Aust Vet J; 1998 Oct; 76(10):677-82. PubMed ID: 9830568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.
    Alber DG; Greensill J; Killington RA; Stokes A
    Res Vet Sci; 1995 Nov; 59(3):205-13. PubMed ID: 8588092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine.
    Yasunaga S; Maeda K; Matsumura T; Kondo T; Kai K
    J Vet Med Sci; 2000 Jul; 62(7):687-91. PubMed ID: 10945284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
    Kukreja A; Walker C; Fitzmaurice T; Awan A; Love DN; Whalley JM; Field HJ
    Vet Microbiol; 1998 Aug; 62(4):303-11. PubMed ID: 9791876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loop-mediated isothermal amplification assays for detection of Equid herpesvirus 1 and 4 and differentiating a gene-deleted candidate vaccine strain from wild-type Equid herpesvirus 1 strains.
    Nemoto M; Tsujimura K; Yamanaka T; Kondo T; Matsumura T
    J Vet Diagn Invest; 2010 Jan; 22(1):30-6. PubMed ID: 20093679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
    Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the Systemic Antibody Response and Antigen Detection Following Intranasal Administration of Two Commercial Equine Herpesvirus-1 Vaccines to Adult Horses.
    Spann K; Barnum S; Pusterla N
    J Equine Vet Sci; 2023 Mar; 122():104229. PubMed ID: 36657628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
    Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
    Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.